Related Experiment Videos
What primary care physicians should know about the toxicity of cancer chemotherapy
1Cleveland Clinic Cancer Center, USA.
Cleveland Clinic Journal of Medicine
|June 1, 1997
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Apical hypertrophic cardiomyopathy: A case series at a Brazilian referral center with a maximal follow-up of 15 years.
Annales de cardiologie et d'angeiologie·2021
Platinum-Gemcitabine-Avastin (PGA) for platinum-resistant/refractory ovarian cancer.
European journal of gynaecological oncology·2018
Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.
Current oncology (Toronto, Ont.)·2018
Surgical intervention in relapsed ovarian cancer is beneficial: contra.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2011
Most elderly patients with subclinical hypothyroidism do not need to be treated.
Cleveland Clinic journal of medicine·2026
Peripheral artery disease: Putting the updated 2024 AHA/ACC guideline into practice.
Cleveland Clinic journal of medicine·2026
Shedding: An updated guide to a common cause of hair loss.
Cleveland Clinic journal of medicine·2026
Interpreting EVERDAC: Deferring arterial cannulation in critically ill patients with shock.
Cleveland Clinic journal of medicine·2026
Actinic keratosis: A clinician's guide to diagnosis and treatment.
Cleveland Clinic journal of medicine·2026
MASLD and MASH: Steatotic liver disease joins the deadly quartet.
Cleveland Clinic journal of medicine·2026
NMA plus antitumor therapy versus antitumor therapy alone in patients with BCLC stage B or C hepatocellular carcinoma and pre-cachexia or cachexia: protocol for a prospective, multicenter, randomized, open-label phase II trial.
Frontiers in gastroenterology (Lausanne, Switzerland)·2026
Cannabinoids in oncology: pharmacology, clinical applications, and translational perspectives.
Frontiers in pharmacology·2026
Phytochemicals in colorectal cancer therapy: emerging mechanisms, translational opportunities, and global research evolution.
Journal of materials chemistry. B·2026
Lessons from oncology: Can cancer lead the way in resistance management?
Evolution, medicine, and public health·2026
Cannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder.
Neuroscience and biobehavioral reviews·2026